# Diagnostic and Prognostic Utility of IL-6 and MMP-7 in Pediatric Immune Mediated Interstitial Lung Disease

> **NCT07559435** · — · NOT_YET_RECRUITING · sponsor: **Sohag University** · enrollment: 60 (estimated)

## Conditions studied

- Pediatric Immune Mediated Interstitial Lung Disease

## Interventions

- **DIAGNOSTIC_TEST:** IL-6 (interlukin 6)
- **RADIATION:** High-Resolution Computed Tomography (HRCT):
- **OTHER:** Pulmonary Function Tests (PFTs)

## Key facts

- **NCT ID:** NCT07559435
- **Lead sponsor:** Sohag University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-04-15
- **Primary completion:** 2028-04
- **Final completion:** 2028-04
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2026-04-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07559435

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07559435, "Diagnostic and Prognostic Utility of IL-6 and MMP-7 in Pediatric Immune Mediated Interstitial Lung Disease". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT07559435. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*